Back to Carlyle Group Inc. Carlyle Group Inc.

TORCNTORCN
12 quarters

Position history for Carlyle Group Inc.Carlyle Group Inc.'s holdings in ADICET BIO INC

As of its Q3 2025 13F, Carlyle Group held 2,948,718 shares of TORCN (Adicet Bio), worth $2.4M. Carlyle Group's 13F filings listed TORCN from Q1 2023 to Q3 2025, 11 quarterly filings. TORCN was 0.1% of Carlyle Group's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$12.2M

Total Shares Change

-2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2025-Q3
Unchanged
2.9M
0.0%
$2.4M0.1%—
0
2025-Q2
Unchanged
2.9M
0.0%
$1.8M0.0%—
0
2025-Q1
Unchanged
2.9M
0.0%
$2.3M0.1%—
0
2024-Q4
Unchanged
2.9M
0.0%
$2.8M0.1%—
0
2024-Q3
Unchanged
2.9M
0.0%
$4.2M0.4%—
0
2024-Q2
Unchanged
2.9M
0.0%
$3.6M0.3%—
0
2024-Q1
Increased
2.9M
+39.4%
$6.9M0.4%—
44
2023-Q4
Unchanged
2.1M
0.0%
$4M0.2%—
0
2023-Q3
Unchanged
2.1M
0.0%
$2.9M0.1%—
0
2023-Q2
Unchanged
2.1M
0.0%
$5.1M0.2%—
0
2023-Q1
New
2.1M
-
$12.2M0.4%—
47

Other major holders of TORCN: RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used